Pharmacotherapy for Pulmonary Hypertension

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Pulmonary arterial hypertension is a serious disease with significant morbidity and mortality. Although it can occur idiopathically, it is more commonly associated with other cardiac or lung diseases. While most of the available therapies have been tested in adult populations and most therapies in children remain off-label, new reports and randomized trials are emerging that inform the treatment of pediatric populations. This review discusses currently available therapies for pediatric pulmonary hypertension, their biological rationales, and evidence for their clinical effectiveness.

Original languageEnglish (US)
Pages (from-to)1130-1146
Number of pages17
JournalPediatric Clinics of North America
Volume59
Issue number5
DOIs
StatePublished - Oct 2012
Externally publishedYes

Fingerprint

Pulmonary Hypertension
Drug Therapy
Pediatrics
Therapeutics
Population
Lung Diseases
Heart Diseases
Morbidity
Mortality

Keywords

  • Endothelin
  • Nitric oxide
  • Phosphodiesterase
  • Prostacyclin
  • Pulmonary hypertension
  • Pulmonary vasculature
  • Vasodilator

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Pharmacotherapy for Pulmonary Hypertension. / Steinhorn, Robin H.

In: Pediatric Clinics of North America, Vol. 59, No. 5, 10.2012, p. 1130-1146.

Research output: Contribution to journalArticle

@article{2d9dc422e1834cbead0499163d089d95,
title = "Pharmacotherapy for Pulmonary Hypertension",
abstract = "Pulmonary arterial hypertension is a serious disease with significant morbidity and mortality. Although it can occur idiopathically, it is more commonly associated with other cardiac or lung diseases. While most of the available therapies have been tested in adult populations and most therapies in children remain off-label, new reports and randomized trials are emerging that inform the treatment of pediatric populations. This review discusses currently available therapies for pediatric pulmonary hypertension, their biological rationales, and evidence for their clinical effectiveness.",
keywords = "Endothelin, Nitric oxide, Phosphodiesterase, Prostacyclin, Pulmonary hypertension, Pulmonary vasculature, Vasodilator",
author = "Steinhorn, {Robin H}",
year = "2012",
month = "10",
doi = "10.1016/j.pcl.2012.07.011",
language = "English (US)",
volume = "59",
pages = "1130--1146",
journal = "Pediatric Clinics of North America",
issn = "0031-3955",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Pharmacotherapy for Pulmonary Hypertension

AU - Steinhorn, Robin H

PY - 2012/10

Y1 - 2012/10

N2 - Pulmonary arterial hypertension is a serious disease with significant morbidity and mortality. Although it can occur idiopathically, it is more commonly associated with other cardiac or lung diseases. While most of the available therapies have been tested in adult populations and most therapies in children remain off-label, new reports and randomized trials are emerging that inform the treatment of pediatric populations. This review discusses currently available therapies for pediatric pulmonary hypertension, their biological rationales, and evidence for their clinical effectiveness.

AB - Pulmonary arterial hypertension is a serious disease with significant morbidity and mortality. Although it can occur idiopathically, it is more commonly associated with other cardiac or lung diseases. While most of the available therapies have been tested in adult populations and most therapies in children remain off-label, new reports and randomized trials are emerging that inform the treatment of pediatric populations. This review discusses currently available therapies for pediatric pulmonary hypertension, their biological rationales, and evidence for their clinical effectiveness.

KW - Endothelin

KW - Nitric oxide

KW - Phosphodiesterase

KW - Prostacyclin

KW - Pulmonary hypertension

KW - Pulmonary vasculature

KW - Vasodilator

UR - http://www.scopus.com/inward/record.url?scp=84867070620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867070620&partnerID=8YFLogxK

U2 - 10.1016/j.pcl.2012.07.011

DO - 10.1016/j.pcl.2012.07.011

M3 - Article

VL - 59

SP - 1130

EP - 1146

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

SN - 0031-3955

IS - 5

ER -